Importantly, this recent study of Obaid and colleagues demonstrated, for the first time, how EGFR targeting combined with the simultaneous co-delivery of IRI and BPD effectively achieved the spatial and temporal synchronization of TOPI inhibition and PDT, allowing PDAC regression by reduction of the tumor mass and concomitant collagen structure perturbation. This evidence concerns the gene EGFR and neoplasm.